| RS2133035336 |
TNNI2
|
Health Risk |
Likely pathogenic |
— |
| RS2133036598 |
WT1
|
Health Risk |
Likely pathogenic |
Drash syndrome, Frasier syndrome |
| RS2133037431 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2133037467 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2133038541 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2133039624 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Generalized hypotonia, Generalized hypotonia |
| RS2133039737 |
HNRNPK
|
Health Risk |
Pathogenic |
— |
| RS2133041569 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133042086 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS2133042191 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133043288 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133043442 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133047947 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Melanoma |
| RS2133048124 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133049150 |
PSAP
|
Health Risk |
Pathogenic |
Krabbe disease due to saposin A deficiency, Krabbe disease due to saposin A deficiency |
| RS2133049724 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133053013 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133053107 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2133059770 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2133067872 |
GNE
|
Health Risk |
Likely pathogenic |
Sialuria, GNE myopathy |
| RS2133068002 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133068813 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS2133072022 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2133072543 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Drash syndrome |
| RS2133073037 |
WT1
|
Health Risk |
Pathogenic |
Frasier syndrome, Wilms tumor 1 |
| RS2133074888 |
WT1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2133075412 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Drash syndrome |
| RS2133076941 |
PUS7
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with abnormal behavior, microcephaly |
| RS2133078032 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133079257 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Thrombocytopenia |
| RS2133080742 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
Bone marrow hypocellularity, Bone marrow hypocellularity |
| RS2133081935 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
Bone marrow hypocellularity, Bone marrow hypocellularity |
| RS2133083597 |
STIM1
|
Health Risk |
Likely pathogenic |
Stormorken syndrome, Myopathy with tubular aggregates |
| RS2133098428 |
BRSK2
|
Health Risk |
Likely pathogenic |
— |
| RS2133101249 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2133102338 |
FXN
|
Health Risk |
Likely pathogenic |
Friedreich ataxia 1, Friedreich ataxia 1 |
| RS2133102575 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2133103216 |
WT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frasier syndrome, Wilms tumor 1 |
| RS2133104077 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2133104138 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS2133104248 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2133104877 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS2133105444 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2133106426 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2133106593 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2133108011 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Frasier syndrome, Wilms tumor 1 |
| RS2133111012 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133113896 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2133114222 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2133120033 |
BRSK2
|
Health Risk |
Pathogenic/Likely pathogenic |
BRSK2-related disorder, BRSK2-related disorder |
| RS2133124899 |
ABCC2
|
Health Risk |
Likely pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS2133126724 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2133127091 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 3 |
| RS2133127123 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2133130286 |
WHRN
|
Health Risk |
Pathogenic |
Usher syndrome type 2D, Usher syndrome type 2D |
| RS2133132945 |
PUS7
|
Health Risk |
Pathogenic |
— |
| RS2133152290 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2133152660 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2133154359 |
EHMT1
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome, Kleefstra syndrome |
| RS2133160637 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2133163213 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Dilated cardiomyopathy 1X |
| RS2133168246 |
EXOSC1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 1F |
| RS2133181057 |
CAT
|
Health Risk |
Pathogenic |
Acatalasia, Acatalasia |
| RS2133193530 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133193948 |
LAMC3
|
Health Risk |
Pathogenic |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS2133202137 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS2133202969 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
— |
| RS2133203419 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS2133209411 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2133224258 |
STIM1
|
Health Risk |
Pathogenic |
Stormorken syndrome, Combined immunodeficiency due to STIM1 deficiency |
| RS2133226731 |
STIM1
|
Health Risk |
Likely pathogenic |
Myopathy, tubular aggregate |
| RS2133226986 |
NEUROG3
|
Health Risk |
Likely pathogenic |
Congenital malabsorptive diarrhea 4, Congenital malabsorptive diarrhea 4 |
| RS2133227010 |
NEUROG3
|
Health Risk |
Pathogenic |
Congenital malabsorptive diarrhea 4, Congenital malabsorptive diarrhea 4 |
| RS2133227148 |
NEUROG3
|
Health Risk |
Pathogenic |
Congenital malabsorptive diarrhea 4, Congenital malabsorptive diarrhea 4 |
| RS2133237860 |
ACTA2
|
Health Risk |
Likely pathogenic |
— |
| RS2133254783 |
PUS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder with abnormal behavior, microcephaly |
| RS2133256226 |
ACTA2
|
Health Risk |
Pathogenic |
Descending aortic dissection, Descending aortic dissection |
| RS2133256406 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS2133261250 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS2133261286 |
ACTA2
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS2133261333 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS2133270221 |
ACTA2
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS2133270267 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS2133273980 |
ACTA2
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS2133277436 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2133281256 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133292794 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2133294899 |
RAG1
|
Health Risk |
Likely pathogenic |
RAG1-related disorder, RAG1-related disorder |
| RS2133295344 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133296385 |
RAG1
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133296872 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133297434 |
RAG1
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133297485 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133297611 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133297645 |
BRSK2
|
Health Risk |
Likely pathogenic |
— |
| RS2133298263 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Histiocytic medullary reticulosis, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2133299037 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133311139 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133312126 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133312466 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |